DESFERAL Side Effects

5653070-7 | Biopsy Kidney Abnormal, Blood Creatinine Increased, Blood Urea Increased, Cardiac Murmur, Chronic Allograft Nephropathy, Condition Aggravated, Creatinine Renal Clearance Decreased, Heart Rate Irregular, Kidney Fibrosis
on Feb 27, 2008 Male patient from GERMANY , 58 years of age, weighting 155.4 lb, was diagnosed with haemosiderosis and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: biopsy kidney abnormal, blood creatinine increased, blood urea increased, cardiac murmur, chronic allograft nephropathy, condition aggravated, creatinine renal clearance decreased, heart rate irregular, kidney fibrosis. Desferal dosage: 2 G/day, Qd. During the same period patient was treated with SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), IMUREK (View Imurek Review and Imurek Label ), BENZBROMARONE (View Benzbromarone Review and Benzbromarone Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5650764-4 | Creatinine Renal Clearance Decreased, Gastrointestinal Disorder, Haemoglobin Decreased, Mitral Valve Incompetence, Platelet Count Decreased, Pulmonary Hypertension, White Blood Cell Count Decreased
Patient was taking Desferal (View Usage). Patient had the following side effects: creatinine renal clearance decreased, gastrointestinal disorder, haemoglobin decreased, mitral valve incompetence, platelet count decreased, pulmonary hypertension (What is pulmonary hypertension?), white blood cell count decreased on Feb 25, 2008 from FRANCE Additional patient health information: Male patient , 19 years of age, was diagnosed with haemochromatosis, pancytopenia, adenovirus infection and. Desferal dosage: 3 Infusions Within 7days. During the same period patient was treated with NOXAFIL (400 Mg, Bid) (View Noxafil Review and Noxafil Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), VISTIDE (1 Mg/kg, Qw3) (View Vistide Review and Vistide Label ). Patient was hospitalized.

5648495-X | Anaemia, Hepatitis C, Pain
Adverse event was reported on Feb 25, 2008 by a Female patient taking Desferal (View Usage) (Dosage: 1 Df, Qw) was diagnosed with anaemia, hepatitis c (What is hepatitis c?) and. Location: BRAZIL , 26 years of age, weighting 119.0 lb, After Desferal was administered, patient had the following side effects: anaemia, hepatitis c (What is hepatitis c?), pain (What is pain?). During the same period patient was treated with INTERFERON (1 Df, Qw) (View Interferon Review and Interferon Label ). Patient was hospitalized.

5626026-8 | Abdominal Pain, Diarrhoea, Duodenal Ulcer, Pyrexia, Red Blood Cell Sedimentation Rate Increased, Transaminases Increased, Yersinia Infection
on Feb 05, 2008 Female patient from GREECE , 14 years of age, was diagnosed with haemosiderosis and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), diarrhoea, duodenal ulcer, pyrexia, red blood cell sedimentation rate increased, transaminases increased, yersinia infection. Desferal dosage: 2500 Mg, Qd. Patient was hospitalized.


5607584-6 | Abdominal Pain, Bacteria Urine, Blood Creatinine Increased, Chills, Dehydration, Escherichia Urinary Tract Infection, Leukocytosis, Nausea, Pyelonephritis
on Jan 23, 2008 Female patient from UNITED STATES , child 5 years of age, weighting 40.34 lb, was diagnosed with blood iron increased and was treated with Desferal (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), bacteria urine, blood creatinine increased, chills, dehydration, escherichia urinary tract infection, leukocytosis, nausea (What is nausea?), pyelonephritis. Desferal dosage: Unk, Qd. Patient was hospitalized.

5591892-1 | Abdominal Pain, Atrial Flutter, Dyspnoea, Hepatomegaly, Left Ventricular Dysfunction, Myocarditis, Tachycardia
Patient was taking Desferal (View Usage). After Desferal was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), atrial flutter, dyspnoea, hepatomegaly, left ventricular dysfunction, myocarditis, tachycardia on Jan 07, 2008 from ITALY Additional patient health information: Female patient , 18 years of age, weighting 147.7 lb, was diagnosed with haemosiderosis and. Desferal dosage: 1375 Mg Daily. During the same period patient was treated with EUTIROX (View Eutirox Review and Eutirox Label ), LUCEN (View Lucen Review and Lucen Label ), CARDIOASPIRINA (View Cardioaspirina Review and Cardioaspirina Label ). Patient was hospitalized.

5571487-6 | Abdominal Pain Upper, Blood Amylase Increased, Cholestasis, Duodenal Ulcer, Gastritis, Lipase Increased, Liver Function Test Abnormal, Nerve Conduction Studies Abnormal, Optic Neuropathy
Adverse event was reported on Dec 17, 2007 by a Female patient taking Desferal (View Usage) (Dosage: 30 Mg/kg, Qd) was diagnosed with haemosiderosis, contraception and. Location: TURKEY , 28 years of age, weighting 92.59 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, blood amylase increased, cholestasis, duodenal ulcer, gastritis, lipase increased, liver function test abnormal, nerve conduction studies abnormal, optic neuropathy. During the same period patient was treated with ESTROGEN NOS (View Estrogen Nos Review and Estrogen Nos Label ). Patient was hospitalized.

5556088-8 | Extraocular Muscle Disorder, Myositis
on Dec 07, 2007 Female patient from UNITED KINGDOM , 73 years of age, weighting 110.2 lb, was treated with Desferal (View Usage). Patient had the following side effects: extraocular muscle disorder, myositis (What is myositis?). Desferal dosage: 8g/4days/week.

5533221-5 | Biopsy Kidney Abnormal, Blood Creatinine Increased, Blood Urea Increased, Cardiac Murmur, Chronic Allograft Nephropathy, Condition Aggravated, Creatinine Renal Clearance Decreased, Heart Rate Irregular, Kidney Fibrosis
on Nov 27, 2007 Male patient from GERMANY , 58 years of age, weighting 155.4 lb, was diagnosed with haemosiderosis and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: biopsy kidney abnormal, blood creatinine increased, blood urea increased, cardiac murmur, chronic allograft nephropathy, condition aggravated, creatinine renal clearance decreased, heart rate irregular, kidney fibrosis. Desferal dosage: 2 G/day, Qd. During the same period patient was treated with SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), IMUREK (View Imurek Review and Imurek Label ), BENZBROMARONE (View Benzbromarone Review and Benzbromarone Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5508402-7 | Diarrhoea, Dizziness, Faeces Discoloured, Upper Gastrointestinal Haemorrhage
Patient was taking Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, dizziness (What is dizziness?), faeces discoloured, upper gastrointestinal haemorrhage on Nov 01, 2007 from UNITED STATES Additional patient health information: Female patient , 16 years of age, weighting 94.14 lb, was diagnosed with haemosiderosis and. Desferal dosage: 1750 Mg, Qd. During the same period patient was treated with TUMS (View Tums Review and Tums Label ). Patient was hospitalized.

5480131-8 | Nephrolithiasis, Renal Colic, Renal Stone Removal
Adverse event was reported on Oct 01, 2007 by a Male patient taking Desferal (View Usage) (Dosage: Unk, Unk) was diagnosed with iron overload and. Location: FRANCE , 75 years of age, Patient had the following side effects: nephrolithiasis, renal colic, renal stone removal.

5467807-3 | Oedema Peripheral, Osteoporosis, Pain, Splint Application, Tenosynovitis
on Sep 18, 2007 Female patient from UNITED STATES , child 9 years of age, was diagnosed with blood iron increased and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: oedema peripheral, osteoporosis (What is osteoporosis?), pain (What is pain?), splint application, tenosynovitis. Desferal dosage: 750 Mg, Qd.

5467805-X | Oedema Peripheral, Osteoporosis, Pain, Splint Application, Tenosynovitis
on Sep 18, 2007 Female patient from UNITED STATES , child 9 years of age, was diagnosed with blood iron increased and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral, osteoporosis (What is osteoporosis?), pain (What is pain?), splint application, tenosynovitis. Desferal dosage: 750 Mg, Qd.

5464031-5 | Oedema Peripheral, Osteoporosis, Pain, Splint Application, Tenosynovitis
Patient was taking Desferal (View Usage). Patient had the following side effects: oedema peripheral, osteoporosis (What is osteoporosis?), pain (What is pain?), splint application, tenosynovitis on Sep 12, 2007 from UNITED STATES Additional patient health information: Female patient , child 9 years of age, was diagnosed with blood iron increased and. Desferal dosage: 750 Mg, Qd.

5461138-3 | Altered State Of Consciousness, Blood Glucose Increased, Glycosylated Haemoglobin Increased, Serum Ferritin Increased
Adverse event was reported on Sep 12, 2007 by a Female patient taking Desferal (View Usage) (Dosage: 1000 Mg, Unk) was diagnosed with haemochromatosis and. Location: JAPAN , 64 years of age, After Desferal was administered, patient had the following side effects: altered state of consciousness, blood glucose increased, glycosylated haemoglobin increased, serum ferritin increased. Patient was hospitalized.

5453653-3 | Abdominal Pain, Addison's Disease, Arthralgia, Back Pain, Cellulitis, Chest Pain, Concomitant Disease Progression, Constipation, Cough
on Sep 05, 2007 Female patient from UNITED STATES , 29 years of age, weighting 143.5 lb, was diagnosed with blood iron increased, dyspepsia, nausea (What is nausea?) and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), addison's disease (What is addison's disease?), arthralgia, back pain (What is back pain?), cellulitis (What is cellulitis?), chest pain (What is chest pain?), concomitant disease progression, constipation (What is constipation?), cough. Desferal dosage: 2200 Mg, Qd. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

5450227-5 | Blood Glucose Increased
on Sep 05, 2007 Female patient from JAPAN , 64 years of age, was diagnosed with haemochromatosis and was treated with Desferal (View Usage). Patient had the following side effects: blood glucose increased. Desferal dosage: 1000 Mg, Unk. Patient was hospitalized.

5381614-1 | Serum Ferritin Increased, Thrombosis, Treatment Noncompliance
Patient was taking Desferal (View Usage). After Desferal was administered, patient had the following side effects: serum ferritin increased, thrombosis, treatment noncompliance on Jun 28, 2007 from UNITED KINGDOM Additional patient health information: Male patient , child 10 years of age, was diagnosed with thalassaemia beta and. Desferal dosage: . During the same period patient was treated with EXJADE (View Exjade Review and Exjade Label ). Patient was hospitalized.

5375867-3 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased
Adverse event was reported on Jun 18, 2007 by a Male patient taking Desferal (View Usage) (Dosage: ) was diagnosed with iron overload, refractory anaemia and. Location: FRANCE , 67 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased. During the same period patient was treated with RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ).

5373620-8 | Hodgkin's Disease
on Jun 19, 2007 Female patient from , 14 years of age, weighting 70.55 lb, was diagnosed with thalassaemia beta and was treated with Desferal (View Usage). Patient had the following side effects: hodgkin's disease (What is hodgkin's disease?). Desferal dosage: 750 Mg/day.

5355133-2 | Copper Deficiency, Neuropathy
on Mar 28, 2007 Female patient from UNITED STATES , 38 years of age, was diagnosed with iron overload and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: copper deficiency, neuropathy. Desferal dosage: . During the same period patient was treated with EXJADE (1125 Mg, Qd; Oral; 1125 Mg, Qd; Oral) (View Exjade Review and Exjade Label ), REVLIMID (View Revlimid Review and Revlimid Label ), BLOOD TRANSFUSION, AUXILIARY PRODUCTS (NO INGREDIENTS SUBSTANCES) (View Blood Transfusion, Auxiliary Products (no Ingredients Substances) Review and Blood Transfusion, Auxiliary Products (no Ingredients Substances) Label ), PLATELETS (View Platelets Review and Platelets Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), ARANESP (View Aranesp Review and Aranesp Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ).

5355131-9 | Eye Disorder, Hypoaesthesia Facial, Mucormycosis, Pain, Sinusitis, Swelling Face
Patient was taking Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: eye disorder, hypoaesthesia facial, mucormycosis, pain (What is pain?), sinusitis (What is sinusitis?), swelling face on Aug 23, 2006 from UNITED STATES Additional patient health information: Male patient , 27 years of age, was diagnosed with iron overload and. Desferal dosage: . Patient was hospitalized.

5355130-7 | Hypersensitivity, Lip Swelling, Pharyngeal Oedema, Urticaria
Adverse event was reported on May 02, 2006 by a Male patient taking Desferal (View Usage) (Dosage: ) . Location: UNITED STATES , 14 years of age, Patient had the following side effects: hypersensitivity, lip swelling, pharyngeal oedema, urticaria.

5321990-9 | Optic Neuritis, Visual Acuity Reduced
on May 07, 2007 Male patient from GERMANY , 79 years of age, weighting 196.2 lb, was diagnosed with haemochromatosis and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: optic neuritis, visual acuity reduced. Desferal dosage: 2 G, Qd. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), EUTHYROX (View Euthyrox Review and Euthyrox Label ), ALLOPURINOL (150 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ).

5317590-7 | Blood Alkaline Phosphatase Increased, Bone Density Decreased, High Turnover Osteopathy, Hypophosphataemia, Osteopenia, Osteoporosis, Renal Tubular Disorder, Serum Ferritin Increased, Urine Calcium Increased
on Apr 25, 2007 Male patient from UNITED KINGDOM , 57 years of age, weighting 136.7 lb, was diagnosed with iron overload, myelodysplastic syndrome and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, bone density decreased, high turnover osteopathy, hypophosphataemia, osteopenia, osteoporosis (What is osteoporosis?), renal tubular disorder, serum ferritin increased, urine calcium increased. Desferal dosage: 10 G, Qw. During the same period patient was treated with BLOOD AND RELATED PRODUCTS (View Blood And Related Products Review and Blood And Related Products Label ), ASCORBIC ACID (250 Mg / Daily) (View Ascorbic Acid Review and Ascorbic Acid Label ).

5295711-2 | Arrhythmia, Cardiac Failure
Patient was taking Desferal (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), cardiac failure on Apr 09, 2007 from TURKEY Additional patient health information: Female patient , 18 years of age, weighting 85.98 lb, was diagnosed with iron overload and. Desferal dosage: 50 Mg/kg/d. Patient was hospitalized.

5289352-0 | Ejection Fraction Decreased, Investigation, Nuclear Magnetic Resonance Imaging Abnormal, Treatment Noncompliance
Adverse event was reported on Mar 27, 2007 by a Female patient taking Desferal (View Usage) (Dosage: ) was diagnosed with thalassaemia and. Location: UNITED KINGDOM , 26 years of age, weighting 141.1 lb, After Desferal was administered, patient had the following side effects: ejection fraction decreased, investigation, nuclear magnetic resonance imaging abnormal, treatment noncompliance. During the same period patient was treated with ASCORBIC ACID (200 Mg, Qd) (View Ascorbic Acid Review and Ascorbic Acid Label ), PREMPAK C (View Prempak C Review and Prempak C Label ), LEVOTHYROXINE SODIUM (50 Ug, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PENICILLIN V (250 Mg, Bid) (View Penicillin V Review and Penicillin V Label ), FOLIC ACID (50 Mg, Qd) (View Folic Acid Review and Folic Acid Label ).

5268023-0 | Blood Alkaline Phosphatase Increased, Bone Density Decreased, High Turnover Osteopathy, Hypophosphataemia, Osteopenia, Osteoporosis, Renal Tubular Disorder, Serum Ferritin Increased, Urine Calcium Increased
on Mar 05, 2007 Male patient from UNITED KINGDOM , 57 years of age, weighting 136.7 lb, was diagnosed with iron overload, myelodysplastic syndrome and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, bone density decreased, high turnover osteopathy, hypophosphataemia, osteopenia, osteoporosis (What is osteoporosis?), renal tubular disorder, serum ferritin increased, urine calcium increased. Desferal dosage: 10 G, Qw. During the same period patient was treated with BLOOD AND RELATED PRODUCTS (View Blood And Related Products Review and Blood And Related Products Label ), ASCORBIC ACID (250 Mg / Daily) (View Ascorbic Acid Review and Ascorbic Acid Label ).

5243725-0 | Ejection Fraction Decreased, Nuclear Magnetic Resonance Imaging Abnormal
on Feb 08, 2007 Female patient from UNITED KINGDOM , 26 years of age, was diagnosed with thalassaemia and was treated with Desferal (View Usage). Patient had the following side effects: ejection fraction decreased, nuclear magnetic resonance imaging abnormal. Desferal dosage: . During the same period patient was treated with EXJADE (Unk, Unk) (View Exjade Review and Exjade Label ).

5232219-4 | Autoimmune Disorder, Rheumatoid Arthritis
Patient was taking Desferal (View Usage). After Desferal was administered, patient had the following side effects: autoimmune disorder, rheumatoid arthritis (What is rheumatoid arthritis?) on Jan 25, 2007 from FRANCE Additional patient health information: Female patient , 39 years of age, was diagnosed with haemosiderosis, osteoporosis (What is osteoporosis?), hypogonadism female and. Desferal dosage: 1250 Mg, Qd. During the same period patient was treated with DIDRONEL (View Didronel Review and Didronel Label ), CLIMASTON (View Climaston Review and Climaston Label ).

5175336-X | Myocardial Infarction
Adverse event was reported on Nov 24, 2006 by a Male patient taking Desferal (View Usage) (Dosage: 200 Mg Once Weekly) was diagnosed with iron overload and. Location: CANADA , 75 years of age, Patient experienced the following unwanted or unexpected effects: myocardial infarction.

5166431-X | Myocardial Infarction
on Nov 24, 2006 Male patient from CANADA , 75 years of age, was diagnosed with iron overload and was treated with Desferal (View Usage). Patient had the following side effects: myocardial infarction. Desferal dosage: 200 Mg Once Weekly.

5146677-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Transaminases Increased
on Oct 27, 2006 Male patient from GERMANY , 63 years of age, weighting 191.8 lb, was diagnosed with haemosiderosis and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, transaminases increased. Desferal dosage: 0.5 G, Qw. During the same period patient was treated with LEVOTHYROXINE SODIUM (100 Mg, Qd) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CALCIMAGON (4000 Mg/day) (View Calcimagon Review and Calcimagon Label ), FUSID (250 Mg, Bid) (View Fusid Review and Fusid Label ), XIPAMIDE (20 Mg, Qd) (View Xipamide Review and Xipamide Label ), RENAGEL (1600 Mg, Bid) (View Renagel Review and Renagel Label ), ATROVENT (1 Df, Bid) (View Atrovent Review and Atrovent Label ), PANTORC (20 Mg, Qd) (View Pantorc Review and Pantorc Label ), AMBROXOL (1 Df, Tid) (View Ambroxol Review and Ambroxol Label ).

5125819-3 | Agranulocytosis, Alanine Aminotransferase Increased, Aplasia Pure Red Cell, Bicytopenia, Bone Marrow Failure, Bone Marrow Transplant, C-reactive Protein Increased, Eosinophilia, Gamma-glutamyltransferase Increased
Patient was taking Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, alanine aminotransferase increased, aplasia pure red cell, bicytopenia, bone marrow failure, bone marrow transplant (What is bone marrow transplant?), c-reactive protein increased, eosinophilia, gamma-glutamyltransferase increased on Jul 06, 2005 from FRANCE Additional patient health information: Male patient , child 7 years of age, weighting 62.83 lb, was diagnosed with blood iron increased and. Desferal dosage: 1500 Mg Mon, Wed, Fri ; 2000 Mg Tues, Thurs. During the same period patient was treated with ACETAMINOPHEN (1800 Mg, Prn) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5114529-4 | Autoimmune Disorder, Rheumatoid Arthritis
Adverse event was reported on Jul 31, 2006 by a Female patient taking Desferal (View Usage) (Dosage: 1250 Mg, Qd) was diagnosed with haemosiderosis, osteoporosis (What is osteoporosis?), hypogonadism female and. Location: FRANCE , 39 years of age, Patient had the following side effects: autoimmune disorder, rheumatoid arthritis (What is rheumatoid arthritis?). During the same period patient was treated with DIDRONEL (View Didronel Review and Didronel Label ), CLIMASTON (View Climaston Review and Climaston Label ).

5105422-1 | Neutropenia
on Sep 05, 2006 Female patient from ITALY , 33 years of age, was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: neutropenia. Desferal dosage: Unk, Unk.

5091168-5 | Gamma-glutamyltransferase Increased, Transaminases Increased
on Aug 11, 2006 Female patient from GERMANY , 85 years of age, was diagnosed with blood aluminium increased and was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: gamma-glutamyltransferase increased, transaminases increased. Desferal dosage: . During the same period patient was treated with SEROQUEL (200 Mg/day) (View Seroquel Review and Seroquel Label ), OXAZEPAM (10 Mg/day) (View Oxazepam Review and Oxazepam Label ), RENAGEL (View Renagel Review and Renagel Label ), AXURA (View Axura Review and Axura Label ).

5087374-6 | Cardiac Discomfort, Dyspnoea, Incorrect Dose Administered, Pulmonary Oedema, Visual Acuity Reduced
Patient was taking Desferal (View Usage). Patient had the following side effects: cardiac discomfort, dyspnoea, incorrect dose administered, pulmonary oedema, visual acuity reduced on Aug 14, 2006 from SWITZERLAND Additional patient health information: Male patient , 70 years of age, was diagnosed with haemosiderosis and. Desferal dosage: 3000 Mg/d. During the same period patient was treated with EXJADE (1000 Mg/d) (View Exjade Review and Exjade Label ), CORDARONE (200 Mg/d) (View Cordarone Review and Cordarone Label ), GUTRON (5 Mg/d) (View Gutron Review and Gutron Label ).

5084100-1 | Gamma-glutamyltransferase Increased, Transaminases Increased
Adverse event was reported on Aug 11, 2006 by a Female patient taking Desferal (View Usage) (Dosage: ) was diagnosed with blood aluminium increased and. Location: GERMANY , 85 years of age, After Desferal was administered, patient had the following side effects: gamma-glutamyltransferase increased, transaminases increased. During the same period patient was treated with SEROQUEL (200 Mg/day) (View Seroquel Review and Seroquel Label ), OXAZEPAM (10 Mg/day) (View Oxazepam Review and Oxazepam Label ), RENAGEL (View Renagel Review and Renagel Label ), AXURA (View Axura Review and Axura Label ).

5076480-8 | Restrictive Pulmonary Disease
on Jun 01, 2006 Female patient from UNITED STATES , 18 years of age, weighting 108.9 lb, was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: restrictive pulmonary disease. Desferal dosage: .

5069532-X | Asthenia, Chills, Cough, Dehydration, Dyspnoea, Pleuritic Pain, Pneumonia, Pyrexia, Renal Failure
on Jul 24, 2006 Male patient from UNITED STATES , 67 years of age, was diagnosed with blood iron increased and was treated with Desferal (View Usage). Patient had the following side effects: asthenia, chills, cough, dehydration, dyspnoea, pleuritic pain, pneumonia (What is pneumonia?), pyrexia, renal failure. Desferal dosage: Unk, Unk. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

5069528-8 | Blister, Skin Disorder, Skin Inflammation, Skin Necrosis
Patient was taking Desferal (View Usage). After Desferal was administered, patient had the following side effects: blister, skin disorder, skin inflammation, skin necrosis on Jul 10, 2006 from NETHERLANDS Additional patient health information: Male patient , child 11 years of age, was diagnosed with thalassaemia and. Desferal dosage: Unk, Unk.

5065308-8 | Aspergillosis, Candida Sepsis, Chills, Febrile Bone Marrow Aplasia, Haemoglobin Decreased, Herpes Zoster, Histiocytosis Haematophagic, Pancytopenia, Platelet Count Decreased
Adverse event was reported on Apr 10, 2006 by a Male patient taking Desferal (View Usage) (Dosage: ) was diagnosed with haemochromatosis, neutropenia and. Location: FRANCE , 59 years of age, Patient experienced the following unwanted or unexpected effects: aspergillosis, candida sepsis, chills, febrile bone marrow aplasia, haemoglobin decreased, herpes zoster, histiocytosis haematophagic, pancytopenia, platelet count decreased. During the same period patient was treated with NEORECORMON ^ROCHE^ (40 000 Iu Daily) (View Neorecormon ^roche^ Review and Neorecormon ^roche^ Label ), GRANOCYTE ^CHUGAI^ (33.6 Miu/day) (View Granocyte ^chugai^ Review and Granocyte ^chugai^ Label ). Patient was hospitalized.

5044973-5 | Aspergillosis, Candida Sepsis, Chills, Febrile Bone Marrow Aplasia, Haemoglobin Decreased, Herpes Zoster, Histiocytosis Haematophagic, Pancytopenia, Platelet Count Decreased
on Apr 10, 2006 Male patient from FRANCE , 59 years of age, was diagnosed with haemochromatosis, neutropenia and was treated with Desferal (View Usage). Patient had the following side effects: aspergillosis, candida sepsis, chills, febrile bone marrow aplasia, haemoglobin decreased, herpes zoster, histiocytosis haematophagic, pancytopenia, platelet count decreased. Desferal dosage: . During the same period patient was treated with NEORECORMON ^ROCHE^ (View Neorecormon ^roche^ Review and Neorecormon ^roche^ Label ), GRANOCYTE ^CHUGAI^ (View Granocyte ^chugai^ Review and Granocyte ^chugai^ Label ). Patient was hospitalized.

5036023-1 | Anaphylactic Reaction, Diarrhoea, Dyspnoea, Eye Swelling, Nausea, Pharyngeal Oedema, Skin Discolouration
on Feb 28, 2006 Female patient from UNITED STATES , 46 years of age, was diagnosed with blood iron increased and was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: anaphylactic reaction, diarrhoea, dyspnoea, eye swelling, nausea (What is nausea?), pharyngeal oedema, skin discolouration. Desferal dosage: Once/single, Injection Nos. Patient was hospitalized.

5036019-X | Abdominal Pain Upper, Anaphylactic Reaction, Chills, Nausea
Patient was taking Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, anaphylactic reaction, chills, nausea (What is nausea?) on Nov 01, 2005 from UNITED STATES Additional patient health information: Female patient , 35 years of age, was diagnosed with blood iron increased and. Desferal dosage: .

5036017-6 | Photopsia, Vision Blurred, Visual Acuity Reduced
Adverse event was reported on Oct 17, 2005 by a Male patient taking Desferal (View Usage) (Dosage: 2 G Qd) was diagnosed with blood iron increased and. Location: UNITED STATES , 73 years of age, weighting 186.1 lb, Patient had the following side effects: photopsia, vision blurred, visual acuity reduced.

5020887-1 | Deep Vein Thrombosis, Haemosiderosis, Hepatic Fibrosis, Hepatocellular Damage, Injection Site Erythema, Injection Site Pain, Injection Site Reaction
on May 30, 2006 Female patient from CANADA , 25 years of age, was treated with Desferal (View Usage). After Desferal was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), haemosiderosis, hepatic fibrosis, hepatocellular damage, injection site erythema, injection site pain, injection site reaction. Desferal dosage: .

5020886-X | Restrictive Pulmonary Disease
on Jun 01, 2006 Female patient from UNITED STATES , 18 years of age, weighting 108.9 lb, was treated with Desferal (View Usage). Patient experienced the following unwanted or unexpected effects: restrictive pulmonary disease. Desferal dosage: .

5010446-9 | Cellulitis, Constipation, Diarrhoea, Injection Site Erythema, Injection Site Pain, Injection Site Warmth, Mental Status Changes, Oxygen Saturation Decreased, Pneumonia Aspiration
Patient was taking Desferal (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?), constipation (What is constipation?), diarrhoea, injection site erythema, injection site pain, injection site warmth, mental status changes, oxygen saturation decreased, pneumonia aspiration on Sep 09, 2005 from UNITED STATES Additional patient health information: Female patient , 29 years of age, weighting 134.9 lb, was diagnosed with blood iron increased and. Desferal dosage: 2200 Mg, Qd. Patient was hospitalized.